Life science News and Research

RSS

DKSH’s distribution centers achieve GMP/GDP certification

On the occasion of DKSH's Annual Logistics and Quality Seminar in Taipei, Business Unit Healthcare organized a Certification Award Ceremony to acknowledge the great success of the certification program. It was presided by Charles Toomey, Executive Vice President Business Unit Healthcare, and Dr. Eize de Boer from SGS (Société Générale de Surveillance).

26 Oct 2010

Panasonic completes investment in CardioNexus

Panasonic Corporation of North America has completed an investment in CardioNexus Corporation, a portfolio company of Houston's Fairway Medical Technologies which works closely with the Texas Medical Center. The move is part of Panasonic's plans to establish itself as a global leader in Personalized Preventive Medicine. The investment follows on an earlier Panasonic initiative to establish a presence in the world's largest medical complex, the Texas Medical Center based in Houston.

From PHC Europe B.V. 26 Oct 2010

Maven Semantic updates Lymphocyte Cell Biology research database

Maven Semantic announces updates to their Lymphocyte Cell Biology research database. The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

26 Oct 2010

ATMI and Austar open new Chinese manufacturing facility

ATMI, Inc. today announced that it has further extended its global biopharma manufacturing footprint with the opening of a new Chinese manufacturing facility as part of a joint venture with Austar, a Hong Kong-based comprehensive service provider to the China pharmaceutical industry.

25 Oct 2010

GE Healthcare signs definitive agreement to acquire Clarient

GE Healthcare, a unit of General Electric Company and Clarient, Inc. announced today that they have entered into a definitive agreement for GE Healthcare to acquire Clarient, a leading player in the fast-growing molecular diagnostics sector.

25 Oct 2010

BIOCOM selects partneringONE platform for Global Life Science Partnering Conference

EBD Group, the leading partnering firm for the global life science industry, today announced that BIOCOM has selected partneringONE as the partnering platform for its inaugural Global Life Science Partnering Conference to be held February 22–24, 2011 at the Estancia Hotel and Spa in La Jolla, California. This conference is an exclusive global partnering and networking forum for senior executives and business development professionals of the life science industry.

22 Oct 2010

FDA purchases AB SCIEX QTRAP 5500 Systems for analysis of the U.S. food supply

AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.

20 Oct 2010

454 Life Sciences enters co-promotional agreement with Fluidigm

454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.

20 Oct 2010

Researchers to study effectiveness of gamma-tocotrienol on prostate cancer cells

Survival rates of the world's most common cancer might soon be increased with a new vitamin E treatment which could significantly reduce tumour regrowth. Queensland University of Technology (QUT) prostate cancer researchers are leading the fight against a disease which kills 3000 Australian men a year.

20 Oct 2010

Integration of XB-BIS and IPA software improve personalized medicine

Ingenuity Systems, the leading provider of information solutions for life science researchers, and TransMed Systems, a translational medicine software and services company, today announced an integration between IPA software and XB Bio-Integration Suite (XB-BIS).

19 Oct 2010

International investors take interest in Australia's biotechnology industry at ALSIS 2010

AusBiotech has kicked off its annual conference with a hugely successful Australasian Life Sciences Investment Summit 2010 in Melbourne today. The premier life science investment conference for Australia and the Asia-Pacific region attracted 150 investors from more than 100 organisations to hear 39 selected Australian biotechnology companies.

19 Oct 2010

Tocotrienols can help reduce triglyceride levels

Scientists from Singapore found that tocotrienols, which are members of the Vitamin E family, are effective in lowering the levels of triglyceride, a form of fat in the blood. High levels of triglyceride are closely linked to an increased risk of cardiovascular and metabolic diseases.

18 Oct 2010

EpiMark Analysis Kit simplifies DNA methylation analysis for epigenetics researchers

New England Biolabs (NEB) has launched a suite of new and validated products designed to simplify DNA methylation analysis for epigenetics researchers. These enzyme-based solutions address some of the challenges of the current methods, including the lack of a reproducible method for the analysis and quantitation of 5-hydroxymethlcytosine (5-hmC) in the epigenome.

15 Oct 2010

Alimera Sciences obtains $32.5M senior secured credit facility

Alimera Sciences, Inc. announced today that it has obtained a $32.5 million senior secured credit facility to help fund its working capital requirements. The credit facility consists of a $20 million revolving line of credit provided by Silicon Valley Bank and a $12.5 million term loan provided by MidCap Financial, LLC and Silicon Valley Bank.

15 Oct 2010

Cellectis bioresearch establishes US subsidiary

Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis, today announced that it has established a US subsidiary, Cellectis bioresearch Inc. Located at the Cambridge Innovation Center in Cambridge, Massachusetts, Cellectis bioresearch Inc. will be responsible for the US-wide promotion of Cellectis bioresearch products and services.

13 Oct 2010

Boyden reports 35% increase in demand for Senior R & D Managers in Life Sciences sector

Fresh hiring decisions are being made at senior management levels, due to CEOs' bold moves to reshape businesses to the more permanent competitive reality, according to the quarterly Boyden Executive Outlook, released today by Boyden Global Executive Search.

12 Oct 2010

Biologists recommend virtual institute for RNA research

A Europe-wide network of labs focusing on RNA research is needed to make the most of RNA's high potential for treating a wide range of diseases. The recommendation for this virtual research institute comes from a panel of biologists at the European Science Foundation in a report published today, 'RNA World: a new frontier in biomedical research'.

12 Oct 2010

BioSystem Development completes $978,000 investment round

BioSystem Development, a privately held life science analytics company, announces a recently completed investment round that raised $978,000 (USD) in funding. The proceeds will be used to expand manufacturing infrastructure and to launch new products into the biopharmaceutical development market.

12 Oct 2010

Health-TIES consortium aims to accelerate innovation in healthcare

On Thursday 7 October, Europe's top regions in healthcare technology will launch the Health-TIES consortium that aims to accelerate innovation in healthcare. The consortium is backed by a three-year grant from the European Commission and is set up to strengthen the research potential of European regions through research-driven clusters of universities, research centres, enterprises and regional authorities.

8 Oct 2010

Bruker closes acquisition of instruments businesses with Veeco

Bruker Corporation today announced the closing of its acquisition of the Atomic Force Microscopy (AFM) and the Optical Industrial Metrology (OIM) instruments businesses from Veeco Instruments, Inc. for $229.4 million in cash.

8 Oct 2010